Shimizu T, Ozawa Y, Nakazawa H, Shishiba Y
Endocrinol Jpn. 1983 Apr;30(2):229-34. doi: 10.1507/endocrj1954.30.229.
The responses of TSH and PRL to intravenous doses of 500 micrograms of TRH were investigated in 26 patients with primary hyperparathyroidism. Fourteen patients (54%) showed low responses of TSH with peak values of less than 5 microU/ml (Group A). Twelve patients showed normal responses of TSH to TRH (Group B). Among the 26, 12 cases belonging to Group A and eight in Group B were reexamined after the correction of serum calcium level by parathyroidectomy. After successful treatment, the responses of TSH to TRH in six of the 12 patients in Group A returned to normal, whereas those in the remaining six were unchanged. The responses in the eight patients in Group B after surgery were not changed when compared to those before treatment. The basal values of PRL and the responses of PRL to TRH were normal in all patients and did not change after treatment. We showed that patients with primary hyperparathyroidism have a high incidence (54%) of suppressed TSH response to TRH. Hypercalcemia was obviously one of the causative factors in inducing this abnormality in six patients. However, persistently suppressed responses of TSH to TRH were observed in the other six patients in Group A even after the correction of the serum calcium level by surgery. This finding suggests a primary failure of the TSH-regulatory mechanism in some cases of primary hyperparathyroidism.
对26例原发性甲状旁腺功能亢进患者静脉注射500微克促甲状腺激素释放激素(TRH)后促甲状腺激素(TSH)和催乳素(PRL)的反应进行了研究。14例患者(54%)TSH反应低下,峰值小于5微单位/毫升(A组)。12例患者TSH对TRH反应正常(B组)。26例患者中,A组的12例和B组的8例在甲状旁腺切除纠正血清钙水平后进行了复查。治疗成功后,A组12例患者中有6例TSH对TRH的反应恢复正常,而其余6例无变化。B组8例患者术后反应与治疗前相比无变化。所有患者PRL的基础值及PRL对TRH的反应均正常,治疗后无变化。我们发现原发性甲状旁腺功能亢进患者中TSH对TRH反应受抑制的发生率很高(54%)。高钙血症显然是6例患者出现这种异常的致病因素之一。然而,A组其他6例患者即使在手术纠正血清钙水平后,TSH对TRH的反应仍持续受抑制。这一发现提示在某些原发性甲状旁腺功能亢进病例中存在TSH调节机制的原发性缺陷。